News
Treating the neurodegenerative disease in its earlier stages is key to slowing cognitive decline. A new study offers hope for ...
Ambroxol is commonly used as an expectorant in cough syrup, helping thin out mucus so people with respiratory illnesses can ...
Explore the link between α2,6-sialyltransferase-I and Alzheimer's disease progression. Understand the new findings on ...
An analysis of 1.7 million patients shows semaglutide may significantly reduce Alzheimer and vascular dementia risk compared ...
13d
TAG24 on MSNAlzheimer’s, Parkinson’s charities find new ways to reuse drugsScientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s disease and Parkinson’s in a new collaboration which aims to discover ...
The unexpected ways Ozempic-like drugs might fight dementia They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the secret ...
A world-first brain scanning technique could identify signs of Alzheimer’s disease long before symptoms appear. The method, which analyses the cell structure of the brain, has been found to ...
A class of HIV drugs known as nucleotide reverse transcriptase inhibitors (NRTIs) may help prevent Alzheimer’s disease, reducing risk by up to 13%, a new study suggests.
A New Biomarker for Measuring Treatment The drug lecanemab was first introduced almost two years ago and has demonstrated good results in terms of reducing the amyloid plaque in the brain among ...
More information: Fertan E, et al, Lecanemab preferentially binds to smaller aggregates present at early Alzheimer's disease, Alzheimer's & Dementia (2025). DOI: 10.1002/alz.70086. alz-journals ...
We were interested in finding out more about the therapeutic effects of these drugs, by studying which type of aggregates they were targeting. “We found that, of the four drugs, lecanemab was the best ...
A new scientific breakthrough may soon offer hope for people affected by Alzheimer’s disease. A group of researchers in Spain has developed a drug candidate that could help fight the condition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results